Cholesterol Cholestrol News
- Ultra Bad LDL Cholestrol Discovered Monday, July 11, 2011 @ 7:44PMAn “ultra bad” form of LDL cholesterol was discovered, which can be bad news for people already at risk for heart disease. LDL already has the label of being the “bad” cholesterol; it promotes heart problems and can ruin cardiovascular … Read More
- ASH announces approval of official health care taxonomy code for Designated Specialists Friday, May 27, 2011 @ 7:13AMToday the American Society of Hypertension, Inc. (ASH) and the ASH Specialist Program Inc. announced the approval of an official health care taxonomy code for Designated Specialists in Clinical Hypertension from the American Medical Association National Uniform Claims Committee.
- Selected first-quarter drug sales for Merck & Co. Friday, April 29, 2011 @ 12:18PMHere are sales figures for the first quarter for Merck & Co.'s 10 top-selling drugs: PRODUCT NAME CONDITION/USE 1Q 2011 SALES 1Q 2010 SALES PERCENT CHANGE
- JDRF, Eli Lilly sign agreement to fund type 1 diabetes research for re-generative medicine Thursday, February 3, 2011 @ 11:46PMEli Lilly and Company and the Juvenile Diabetes Research Foundation today announced that they have signed an agreement to fund early-stage research that could enable patients with type 1 diabetes to regenerate insulin-producing cells destroyed by the disease.
- Eating oatmeal for cholesterol but just not loving it? Tuesday, January 25, 2011 @ 12:04PMNutrition columnist Molly Kimball on eating right.
- 2. New drug claims steep drop in bad cholesterol; boosts good cholestrol Wednesday, November 17, 2010 @ 7:37PMCHICAGO: An experimental drug boosted good cholesterol so high and dropped bad cholesterol so low in a study that doctors were stunned and voiced renewed hopes for an entirely new way of preventing heart attacks and strokes.
- AHA/ASA announce need for comprehensive hospital certification program for heart and stroke care Monday, November 15, 2010 @ 5:56AMThe American Heart Association should develop a comprehensive hospital certification program with policies and evidence-based criteria for cardiovascular disease and stroke care in the United States, according to an American Heart Association Presidential Advisory published in Circulation: Journal of the American Heart Association.
- Stronger anti-cholestrol drugs can cut heart attack deaths Tuesday, November 9, 2010 @ 4:25AMLondon, Nov 9 : More powerful statins - drugs used to lower cholesterol levels associated with cardiovascular diseases - can cut down deaths from heart attacks, a study shows.
- 28,000 S'poreans over 85 Thursday, September 16, 2010 @ 3:13AMTHERE are 28,000 elderly Singaporeans over 85 years who do not have enough funds in their Medisave to meet their healthcare costs. Half of them need outpatient treatment for a range of illnneses such as diabetes, high blood pressure or high cholestrol.
- Non-stick cookware may lead to increased cholestrol in children Wednesday, September 8, 2010 @ 2:27PMA new study suggests compounds used in non-stick cookware may be linked to high cholesterol in children and teens.
- Kuya Kim diagnosed with hypothyroidism Wednesday, August 18, 2010 @ 11:32PMMANILA, Philippines - “TV Patrol’s” resident weatherman Kim Atienza, who suffered from a mild stroke last week, bared he was diagnosed with hypothyroidism.
- MJFF supports Ceregene's CERE-120 Phase 2 study for PD with $2.5M award Wednesday, June 23, 2010 @ 1:37AMThe Michael J. Fox Foundation for Parkinson's Research (MJFF) will provide $2.5 million to support Ceregene Inc.'s new Phase 2 study of CERE-120. This novel gene therapy product delivers the gene for neurturin, a potent neurotrophic (growth) factor that has shown potential to improve the status of degenerating neurons in both preclinical and clinical studies. CERE-120 has the potential to ...
- Ranbaxy launches cholestrol reducing medication Lipogen in South African market Tuesday, June 8, 2010 @ 6:05AMRanbaxy, a wholly-owned subsidiary of Ranbaxy Laboratories Limited, has launched Lipogen (atorvastatin) 10, 20, 40 and 80mg into the South African market. Ranbaxy is the first generic pharmaceutical company to launch a generic atorvastatin in South Africa.